Effect of Quercetin and Its Metabolite on Caveolin-1 Expression Induced by Oxidized LDL and Lysophosphatidylcholine in Endothelial Cells
Overview
Affiliations
Oxidized low-density lipoprotein contributes to atherosclerotic plaque formation, and quercetin is expected to exert anti-atherosclerotic effects. We previously reported accumulation of conjugated quercetin metabolites in the aorta of rabbits fed high-cholesterol diets with quercetin glucosides, resulting in attenuation of lipid peroxidation and inhibition of lipid accumulation. Caveolin-1, a major structural protein of caveolae in vascular endothelial cells, plays a role in atherosclerosis development. Here we investigated effects of oxidized low-density lipoprotein, quercetin and its metabolite, quercetin 3-O-β-glucuronide, on caveolin-1 expression. Oxidized low-density lipoprotein significantly upregulated caveolin-1 mRNA expression. An oxidized low-density lipoprotein component, lysophosphatidylcholine, also induced expression of both caveolin-1 mRNA and protein. However, lysophosphatidylcholine did not affect the location of caveolin-1 proteins within caveolae structures. Co-treatment with quercetin or quercetin 3-O-β-glucuronide inhibited lysophosphatidylcholine-induced caveolin-1 expression. Quercetin and quercetin 3-O-β-glucuronide also suppressed expression of adhesion molecules induced by oxidized low-density lipoprotein and lysophosphatidylcholine. These results strongly suggest lysophosphatidylcholine derived from oxidized low-density lipoprotein contributes to atherosclerotic events by upregulating caveolin-1 expression, resulting in induction of adhesion molecules. Quercetin metabolites are likely to exert an anti-atherosclerotic effect by attenuating caveolin-1 expression in endothelial cells.
Terao J J Clin Biochem Nutr. 2024; 75(1):7-16.
PMID: 39070533 PMC: 11273273. DOI: 10.3164/jcbn.24-30.
Citrus flavonoids and adhesion molecules: Potential role in the management of atherosclerosis.
Ebrahimi F, Ghazimoradi M, Fatima G, Bahramsoltani R Heliyon. 2023; 9(11):e21849.
PMID: 38028000 PMC: 10663934. DOI: 10.1016/j.heliyon.2023.e21849.
Terao J Antioxidants (Basel). 2023; 12(2).
PMID: 36829817 PMC: 9952755. DOI: 10.3390/antiox12020258.
Zhu H, Xiong X, Lu Y, Wu H, Zhang Z, Sun M Ann Transl Med. 2022; 10(20):1098.
PMID: 36388817 PMC: 9652507. DOI: 10.21037/atm-22-3678.
Kondo-Kawai A, Sakai T, Terao J, Mukai R J Clin Biochem Nutr. 2021; 69(1):28-36.
PMID: 34376911 PMC: 8325769. DOI: 10.3164/jcbn.20-190.